Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 26, 2021 at 07:44 am EDT
Share
Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,498.95 million compared to CNY 1,461.32 million a year ago. Revenue was CNY 1,498.95 million compared to CNY 1,461.32 million a year ago. Net income was CNY 292.19 million compared to CNY 252.27 million a year ago. Basic earnings per share from continuing operations was CNY 0.7358 compared to CNY 0.6376 a year ago. Diluted earnings per share from continuing operations was CNY 0.7358 compared to CNY 0.6376 a year ago.
TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. 
